TY  - GEN
AU  - Huhn,Gregory D
AU  - Eron,Joseph J
AU  - Girard,Pierre-Marie
AU  - Orkin,Chloe
AU  - Molina,Jean-Michel
AU  - DeJesus,Edwin
AU  - Petrovic,Romana
AU  - Luo,Donghan
AU  - Van Landuyt,Erika
AU  - Lathouwers,Erkki
AU  - Nettles,Richard E
AU  - Brown,Kimberley
AU  - Wong,Eric Y
TI  - Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study
SN  - 1742-6405
PY  - 2020///0505
KW  - Adenine
KW  - analogs & derivatives
KW  - Adult
KW  - Aged
KW  - Alanine
KW  - Anti-HIV Agents
KW  - therapeutic use
KW  - Antiretroviral Therapy, Highly Active
KW  - Cobicistat
KW  - Darunavir
KW  - Drug Combinations
KW  - Drug Substitution
KW  - Emtricitabine
KW  - Female
KW  - HIV Infections
KW  - drug therapy
KW  - HIV-1
KW  - drug effects
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Protease Inhibitors
KW  - Sustained Virologic Response
KW  - Tablets
KW  - Tenofovir
KW  - Viral Load
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/s12981-019-0235-1
ER  -